Clinical Trials News

Medindia's Press Release’ section provides the latest press release on Clinical Trials from across the world for the global audience. This page links to 3637 Clinical Trials press releases.

Approaches For Extending Sample Stability For Flow Cytometry Analysis In Clinical Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, the featured speakers will discuss the challenges of achieving extended stability for flow cytometry samples and define several approaches to extending flow cytometry ...

Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China

SUZHOU, China , Aug. 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...

Be The Difference Foundation Announces Collaboration With Mary Crowley Cancer Research and The Clearity Foundation to Increase Support For Clinical Trial Participants

New "Caring For Her" program facilitates access to clinical trials and psychosocial support services for women with ovarian cancer DALLAS , July 31, 2020 /PRNewswire-PRWeb/ -- Be T...

Medrio Launches Trial Talks, a Global Clinical Trials Podcast

Medrio, Inc., released episode one of six for the first season of their new podcast, Trial Talks. SAN FRANCISCO , July 30, 2020 /PRNewswire-PRWeb/ -- Medrio, Inc., the leading prov...

Virtual and Hybrid Study Considerations for Dermatology Clinical Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, the featured speakers will discuss Hybrid/Virtual trials in the clinical research space and technological advances in mobile health platforms in dermatology clinical t...

AbbVie Announces Positive Phase 3 Data for Atogepant in Migraine Prevention

- Phase 3 ADVANCE trial evaluating atogepant meets primary endpoint of statistically significant reduction from baseline in mean monthly migraine days, compared to placebo, for all doses ev...

Fund+ Establishes ExeVir Bio with VIB and UCB to Accelerate Development of New Treatment Conferring Broad Protection Against Covid-19

- Leads Series A Financing of EUR23M to Advance Lead Novel Llama-derived Antibody into Clinical Trials LEUVEN, Belgium , July 28, 2020 /PRNewswire/ -- Fund+, an investment firm foc...

CenterWatch Announces -- Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

Making the move to a risk-based monitoring process for your clinical trials? New manual provides customizable SOPs to make the transition easier. FALLS CHURCH, Va. , July 24, 2020 ...

ERT Introduces Industry's First Fully Compliant Respiratory Solution in Adherence with New ATS/ERS Guidelines

Enhanced solution improves data accuracy to increase respiratory clinical trial efficiencies. PHILADELPHIA , July 23, 2020 /PRNewswire-PRWeb/ -- ERT , the global leader in clinica...

Life Sciences Industry Accelerates Growth and Navigates COVID-19 with eClinical Solutions' ASCEND Clinical Data Services

Boston pharma tech innovator supports faster clinical trials and regulatory drug approvals with advanced technology platforms and statistical expertise MANSFIELD, Mass. , July 23, 2...

Clinical Trials News »

Clinical Trial Tests Oral Cancer Drug to Fight COVID-19

Clinical Trial Tests Oral Cancer Drug to Fight COVID-19

New clinical trial finds oral cancer drug called ibrutinib can combat respiratory symptoms of COVID-19....

Alzheimer's Risk Factors may be Apparent in Adolescents and Young Adults

Alzheimer's Risk Factors may be Apparent in Adolescents and Young Adults

Adolescence and young adults with high blood pressure, diabetes, or two or more heart health risk factors have significantly worse late-life cognition, finds a new study....

UK’s Vaccine Against COVID-19 is Safe, Induces Immune Reaction: The Lancet

UK’s Vaccine Against COVID-19 is Safe, Induces Immune Reaction: The Lancet

Novel coronavirus vaccine created by the University of Oxford appears to be safe and induces a strong immune response within the body, reports a new study. The findings of the study are published in the journal The Lancet ....

Wuhan-made Chinese COVID-19 Vaccine Found to be Safe: The Lancet

Wuhan-made Chinese COVID-19 Vaccine Found to be Safe: The Lancet

Phase 2 trial results for a COVID-19 vaccine candidate, conducted in China's Wuhan, was safe and induced immune response, reports a new study. The findings of the study are published in the journal The Lancet ....

Topical PDE-4 Inhibitor for Chronic Plaque Psoriasis Effective in Phase 2b Trial

Topical PDE-4 Inhibitor for Chronic Plaque Psoriasis Effective in Phase 2b Trial

Topical roflumilast, a potent, selective topical phosphodiesterase-4 inhibitor, showed marked improvement in patients with chronic plaque psoriasis, including challenging lesions...

More Clinical Trials News

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store